Functional roles | Cancer types | Related genes | Related pathways | References |
---|---|---|---|---|
Proliferation | CRC | miR-217/TCF7L2, hnRNPUL2, miR-181a-5p/beta-catenin/TCF4, EZH2/DUSP5/CDKN1A | Wnt/beta-catenin, Ras/MAPK signaling pathway | |
Glioma | miR-384/PIWIL4, miR-136-5p/Bcl-2/Wnt2, miR-186/XIAP/PAK7 | mTOR signaling pathway | ||
Lung caner | miR-338-3p, CDK4, CDK6, CCNE1 | PI3K/AKT signaling pathway | ||
HCC | miR-136-5P/IRX5,miR-217/MAPK1, miR-203/BCAT1, miR-384/NF-kappaB/p-AKT, E-cadherin, ZO-1, N-cadherin, slug, twist, vimentin | PI3K/Akt/GSK3beta-Wnt/beta-catenin, mTOR signaling pathway | ||
BC | miR-136, SF3B1 | Wnt/beta-catenin signaling pathway | ||
GC | miR-145/E2F3 | PI3K/AKT signaling pathway | ||
RCC | CCND1, CCNE1 | Wnt/beta-catenin signaling pathway | ||
Osteosarcoma | Notch1, JAG1, N-cadherin, vimentin, E-cadherin | Notch1 signaling pathway | [36] | |
Cervical cancer | Not determined | PI3K/AKT signaling pathway | ||
Ovarian cancer | TP53 | Not determined | [66] | |
MM | miR-451 | Not determined | [47] | |
PTC | miR-384/PTN | Not determined | [43] | |
Pancreatic cancer | miR-384/IRS1 | Not determined | [50] | |
TSCC | miR-384/KRAS/cdc42 | Not determined | [42] | |
Melanoma | miR-205/CCL18, SF3B1 | Not determined | ||
Medulloblastoma | Not determined | Not determined | [83] | |
Bladder cancer | Not determined | Not determined | [68] | |
Invasion and migration | CRC | miR-136/E2F1, miR-217/TCF7L2, hnRNPUL2 | Wnt/beta-catenin, Ras/MAPK Signaling Pathway | |
Glioma | miR-384/PIWIL4/STAT3, miR-136-5p/Bcl-2/Wnt2, miR-186/XIAP/PAK7 | mTOR signaling pathway | ||
Lung caner | miR-338-3p | Not determined | [25] | |
HCC | miR-136-5P/IRX5, miR-217/MAPK1, miR-203/BCAT1, miR-384/NF-kappaB/p-AKT,E-cadherin, ZO-1, N-cadherin, slug, twist, vimentin | Wnt/beta-catenin signaling pathway | ||
BC | miR-136 | Wnt/beta-catenin signaling pathway | [27] | |
GC | Not determined | PI3K/AKT signaling pathway | [28] | |
Osteosarcoma | Notch1, JAG1, N-cadherin, vimentin, E-cadherin | Notch1 signaling pathway | [36] | |
Cervical cancer | Not determined | PI3K/AKT signaling pathway | [80] | |
PTC | miR-384/PTN | Not determined | [43] | |
Pancreatic cancer | miR-384/IRS1 | Not determined | [50] | |
TSCC | miR-384/KRAS/cdc42 | Not determined | [42] | |
Melanoma | miR-205/CCL18 | Not determined | [81] | |
Gallbladder cancer | DMBT1/C-IAP1 | PI3K-AKT signaling pathway | [76] | |
Bladder cancer | Not determined | Not determined | [68] | |
Apoptosis | CRC | EZH2/DUSP5/CDKN1A | Not determined | [48] |
Glioma | miR-384/PIWIL4/STAT3, EGFR/TKI, Bcl2/Bax, miR-136-5p/Bcl-2/Wnt2, miR-186/XIAP/PAK7, FOXM1 | EGFR, NF-kappaB, JAK/STAT signaling pathway | ||
HCC | Not determined | mTOR signaling pathway | [77] | |
Cervical cancer | Not determined | PI3K/AKT signaling pathway | [34] | |
MM | miR-451 | Not determined | [47] | |
Medulloblastoma | Not determined | Not determined | [83] | |
Bladder cancer | Not determined | Not determined | [68] | |
Chemoresistance | CRC | miR-181a-5p/beta-catenin/TCF4, miR-136/E2F1 | Wnt/beta-catenin signaling pathway | |
Metabolism | CRC | IGF | PI3K/Akt/mTOR, Raf/MAPK, insulin/IGF signaling pathway | [74] |
Radiosensitivity | Lung caner | PRC2/EZH2/p21 | Not determined | [64] |
Inflammation | Glioma | FOXM1 | NF-kappaB, JAK/STAT, toll-like receptor (TLR) signaling pathway |